MARKER THERAPEUTICS INC's ticker is MRKR and the CUSIP is 57055L107. A total of 3 filers reported holding MARKER THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $3,058 | -23.6% | 11,500 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $4,000 | 0.0% | 11,500 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $4,000 | -20.0% | 11,500 | 0.0% | 0.00% | -50.0% |
Q1 2022 | $5,000 | -54.5% | 11,500 | 0.0% | 0.00% | -33.3% |
Q4 2021 | $11,000 | -42.1% | 11,500 | +0.2% | 0.00% | -50.0% |
Q3 2021 | $19,000 | – | 11,475 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital Management LP | 2,000,000 | $15,840,000 | 6.76% |
NEA Management Company, LLC | 5,000,000 | $39,600,000 | 2.77% |
APIS CAPITAL ADVISORS, LLC | 90,000 | $713,000 | 1.07% |
683 Capital Management, LLC | 560,000 | $4,435,000 | 0.40% |
Perceptive Advisors | 2,000,000 | $15,840,000 | 0.36% |
One68 Global Capital, LLC | 30,000 | $238,000 | 0.30% |
CAXTON CORP | 23,915 | $189,000 | 0.22% |
Riggs Asset Managment Co. Inc. | 46,019 | $364,000 | 0.20% |
MYDA Advisors LLC | 68,000 | $539,000 | 0.18% |
MYDA Advisors LLC | 68,100 | $539,000 | 0.18% |